WO2003033506A1 - Aminoborane acid derivative and proteasome inhibitory drug containing the same - Google Patents
Aminoborane acid derivative and proteasome inhibitory drug containing the same Download PDFInfo
- Publication number
- WO2003033506A1 WO2003033506A1 PCT/JP2002/010450 JP0210450W WO03033506A1 WO 2003033506 A1 WO2003033506 A1 WO 2003033506A1 JP 0210450 W JP0210450 W JP 0210450W WO 03033506 A1 WO03033506 A1 WO 03033506A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aminoborane
- acid derivative
- same
- proteasome inhibitory
- remedy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003536245A JPWO2003033506A1 (en) | 2001-10-12 | 2002-10-08 | Aminoboranoic acid derivatives and proteasome inhibitors containing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001314731 | 2001-10-12 | ||
JP2001-314731 | 2001-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003033506A1 true WO2003033506A1 (en) | 2003-04-24 |
Family
ID=19132995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/010450 WO2003033506A1 (en) | 2001-10-12 | 2002-10-08 | Aminoborane acid derivative and proteasome inhibitory drug containing the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2003033506A1 (en) |
WO (1) | WO2003033506A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003059898A2 (en) * | 2002-01-08 | 2003-07-24 | Eisai Co. Ltd. | Eponemycin and epoxomicin analogs and uses thereof |
JP2007502304A (en) * | 2003-08-14 | 2007-02-08 | セファロン、インク. | Proteasome inhibitors and methods of using them |
EP2088205A1 (en) | 2008-02-11 | 2009-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | PSMB10: A diagnosis marker and therapeutic target of chronic rejection. |
CN102127052A (en) * | 2011-01-25 | 2011-07-20 | 浙江大学 | Method for synthesizing 1,4-benzdioxan-2-carboxylic acid |
KR101441703B1 (en) | 2006-06-19 | 2014-09-17 | 오닉스 세라퓨틱스, 인크. | Peptide epoxyketones for proteasome inhibition |
US9126997B1 (en) | 2010-09-07 | 2015-09-08 | Northwestern University | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma |
JP2016172768A (en) * | 2016-06-27 | 2016-09-29 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Proteasome inhibitor |
AU2016202747B2 (en) * | 2004-03-30 | 2017-11-23 | Millennium Pharmaceuticals, Inc. | Synthesis of boronic ester and acid compounds |
CN107474062A (en) * | 2004-03-30 | 2017-12-15 | 千禧药品公司 | The synthesis of the ester and acid compound of boron |
WO2018159628A1 (en) * | 2017-02-28 | 2018-09-07 | 国立大学法人北海道大学 | Amino acid type acylborane and method for producing same |
US10526351B2 (en) | 2008-06-17 | 2020-01-07 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
JP2021526159A (en) * | 2018-05-28 | 2021-09-30 | チャンスー チア タイ フェンハイ ファーマシューティカル カンパニー リミテッドJiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Synthesis and use of peptide boronic acid esters compounds |
US11241448B2 (en) | 2014-05-20 | 2022-02-08 | Millennium Pharmaceuticals, Inc. | Methods for cancer therapy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
-
2002
- 2002-10-08 WO PCT/JP2002/010450 patent/WO2003033506A1/en active Application Filing
- 2002-10-08 JP JP2003536245A patent/JPWO2003033506A1/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7524883B2 (en) | 2002-01-08 | 2009-04-28 | Eisai R&D Management Co., Ltd. | Eponemycin and epoxomicin analogs and uses thereof |
WO2003059898A3 (en) * | 2002-01-08 | 2004-02-26 | Eisai Co Ltd | Eponemycin and epoxomicin analogs and uses thereof |
WO2003059898A2 (en) * | 2002-01-08 | 2003-07-24 | Eisai Co. Ltd. | Eponemycin and epoxomicin analogs and uses thereof |
JP4917431B2 (en) * | 2003-08-14 | 2012-04-18 | セファロン、インク. | Proteasome inhibitors and methods of using them |
JP2007502304A (en) * | 2003-08-14 | 2007-02-08 | セファロン、インク. | Proteasome inhibitors and methods of using them |
AU2016202747B2 (en) * | 2004-03-30 | 2017-11-23 | Millennium Pharmaceuticals, Inc. | Synthesis of boronic ester and acid compounds |
CN107474062A (en) * | 2004-03-30 | 2017-12-15 | 千禧药品公司 | The synthesis of the ester and acid compound of boron |
KR101441703B1 (en) | 2006-06-19 | 2014-09-17 | 오닉스 세라퓨틱스, 인크. | Peptide epoxyketones for proteasome inhibition |
EP2088205A1 (en) | 2008-02-11 | 2009-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | PSMB10: A diagnosis marker and therapeutic target of chronic rejection. |
US10526351B2 (en) | 2008-06-17 | 2020-01-07 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US11485746B2 (en) | 2008-06-17 | 2022-11-01 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US10604538B2 (en) | 2008-06-17 | 2020-03-31 | Millenium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US9126997B1 (en) | 2010-09-07 | 2015-09-08 | Northwestern University | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma |
CN102127052A (en) * | 2011-01-25 | 2011-07-20 | 浙江大学 | Method for synthesizing 1,4-benzdioxan-2-carboxylic acid |
CN102127052B (en) * | 2011-01-25 | 2013-05-01 | 浙江大学 | Method for synthesizing 1,4-benzdioxan-2-carboxylic acid |
US11241448B2 (en) | 2014-05-20 | 2022-02-08 | Millennium Pharmaceuticals, Inc. | Methods for cancer therapy |
JP2016172768A (en) * | 2016-06-27 | 2016-09-29 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Proteasome inhibitor |
JPWO2018159628A1 (en) * | 2017-02-28 | 2019-12-26 | 国立大学法人北海道大学 | Amino acid type acylborane and method for producing the same |
WO2018159628A1 (en) * | 2017-02-28 | 2018-09-07 | 国立大学法人北海道大学 | Amino acid type acylborane and method for producing same |
JP7244921B2 (en) | 2017-02-28 | 2023-03-23 | 国立大学法人北海道大学 | Amino acid-type acylborane and method for producing the same |
JP2021526159A (en) * | 2018-05-28 | 2021-09-30 | チャンスー チア タイ フェンハイ ファーマシューティカル カンパニー リミテッドJiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Synthesis and use of peptide boronic acid esters compounds |
JP7314259B2 (en) | 2018-05-28 | 2023-07-25 | チャンスー チア タイ フェンハイ ファーマシューティカル カンパニー リミテッド | Synthesis and use of peptide boronic ester compounds |
Also Published As
Publication number | Publication date |
---|---|
JPWO2003033506A1 (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
MY137944A (en) | Specific glucocorticoid compounds having anti-inflammatory activity | |
EP1396493A4 (en) | Heterocyclic compounds | |
WO2009020140A1 (en) | Adamantylurea derivative | |
WO2005037825A3 (en) | Protein kinase inhibitors | |
WO2003033506A1 (en) | Aminoborane acid derivative and proteasome inhibitory drug containing the same | |
WO2005018557A3 (en) | Substituted pyridinones | |
WO2006024486A3 (en) | Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents | |
WO2005060972A3 (en) | Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection | |
EP1953154A4 (en) | Morpholine type cinnamide compound | |
NZ541974A (en) | Nucleotide phosphoramidates as anticancer agents | |
EP1361220A4 (en) | Cyclic compounds having thrombopoietin receptor agonism | |
EP1982982A4 (en) | Novel coumarin derivative having antitumor activity | |
TW200615266A (en) | Organic compounds | |
NO20055092L (en) | Substituted pyrimid ions | |
TW200745034A (en) | New compounds | |
TW200616961A (en) | Carbostyril compound | |
EP1839662A4 (en) | Antitumor agent | |
TW200616636A (en) | Novel compounds | |
SI1730144T1 (en) | Substituted 1,4,8-triazaspiro 4.5 decan-2-one compounds | |
CA2336412A1 (en) | Medicament for treatment of diabetes | |
WO2005040171A8 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
WO2004082581A3 (en) | Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof | |
EP1634874A4 (en) | Imidazolidine derivative | |
WO2006036981A3 (en) | Small molecule modulators of cytokine activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003536245 Country of ref document: JP |
|
122 | Ep: pct application non-entry in european phase |